Nasdaq · Healthcare
ENSIGN GROUP, INC (ENSG)
As-reported financials and recent SEC filings for ENSIGN GROUP, INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.03B
Net income
$344.0M
Net margin
6.8%
Diluted EPS
$5.84
ROE
15.4%
P/E (TTM)
26.6×
Market cap
$9.53B
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.03B | $4.24B | $3.71B | $3.03B | $2.63B |
| Gross profit | $1.01B | $860.6M | $766.8M | $671.0M | $607.6M |
| Operating income | $425.3M | $358.3M | $255.4M | $296.8M | $260.5M |
| Net income | $344.0M | $298.0M | $209.4M | $224.7M | $194.7M |
| Diluted EPS | $5.84 | $5.12 | $3.65 | $3.95 | $3.42 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-15
View on EDGAR →8-K2026-06-10
View on EDGAR →42026-06-04
View on EDGAR →1442026-06-02
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →Go deeper on ENSG
Search ENSIGN GROUP, INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.